AFP Specific T Cell Receptor Transduced T Cells Injection(C-TCR055) in Unresectable Hepatocellular Carcinoma
Clinical trial NCT03971747 · UNKNOWN
Trial details
- NCT number
- NCT03971747
- Sponsor
- Shanghai AbelZeta Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-06
- Primary completion
- 2020-06-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.